Our lab studies the genetic basis of rare Mendelian disorders and develops high-throughput cell-based assays and functional genomics techniques to experimentally characterize the effects of clinically observed variants. We also use genome sequencing and informatics approaches to increase the usability of genetic data at the bedside and improve clinical care.